Health ❯ Public Health ❯ Obesity

Weight Management

GLP-1 Drugs Medications Weight-loss Drugs Pharmaceuticals Weight Loss Drugs Anti-Obesity Medications Injection Therapies GLP-1 Medications Impact on Industries Prehabilitation Lifestyle Intervention Mindfulness Weight-Loss Injections NHS Services Clinical Implications NHS Policies Prescription Medications Treatment Strategies Weight Loss Treatments Cravings Personalized Medicine Drug Accessibility Semaglutide BMI Measurement Medication Access Mounjaro Weight Loss Injections Dietary Drugs Pharmaceutical Interventions Healthcare Services Medications for Obesity Medication Use

Global Analysis Shows Obesity Slowing in Wealthy Nations and Accelerating Elsewhere

A new measure of year‑to‑year change flags record 2024 increases in many countries.

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

U.S. Obesity Rate Drops to 37% as GLP-1 Use Surges, Gallup Finds